Guhan Pharmaceutical Group Co., Ltd. (000590)の価格はいくらですか

Guhan Pharmaceutical Group Co., Ltd. (000590)の価格は$1.37です

Guhan Pharmaceutical Group Co., Ltd. (000590)の時価総額は何ですか

Guhan Pharmaceutical Group Co., Ltd. (000590)の時価総額は$328.98Mです

Guhan Pharmaceutical Group Co., Ltd. (000590) の収益

Guhan Pharmaceutical Group Co., Ltd., along with its various subsidiaries, operates as a prominent Chinese pharmaceutical enterprise. The company focuses on the production and distribution of traditional Chinese medicine (TCM), conventional chemical pharmaceuticals, and health supplements within the domestic market. Its business activities are organized into specific segments, including the manufacturing and sale of traditional Chinese medicine, the manufacturing and sale of Western medicine, and a range of other operations. The company boasts a comprehensive product catalog featuring both prescription and over-the-counter (OTC) drugs. This selection includes tonics and health-boosting preparations, medications for cardiovascular and cerebrovascular conditions, nutritional products for children, cold and flu remedies, and detoxifying agents. Beyond its core manufacturing, Guhan Pharmaceutical is involved in a diverse array of additional services and ventures. These encompass health and nutrition advisory services, the cultivation of Chinese medicinal herbs, extensive medical research and experimental development, planning for cultural and artistic exchanges, general medical consultations, online sales, technology promotion, consulting agent services, outpatient care, and comprehensive pharmaceutical wholesale and retail operations. Founded in 1956, the company is headquartered in Hengyang, China. It was previously known as Tus-Pharmaceutical Group Co., Ltd., officially adopting its current name, Guhan Pharmaceutical Group Co., Ltd., in November 2025.

年	収益	変化
提供された日付のデータは十分ではありません。

年

収益

変化

提供された日付のデータは十分ではありません。

企業	収益	収益の差	国
Royalty Pharma plc RPRX.US	$2.54B	-	US
Swedish Orphan Biovitrum AB SOBI.ST	-	-	SE
Ipsen S.A. IPN.PA	-	-	FR
Recordati Industria Chimica e Farmaceutica S.p.A. REC.MI	-	-	IT
Corcept Therapeutics Incorporated CORT.US	$830.81M	-	US

企業

収益

収益の差

国